Biocept Inc. | Ownership

Companies that own Biocept Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Geode Capital Management LLC
222,660
9.78%
220,414
0%
06/30/2018
Heights Capital Management, Inc.
45,588
2%
45,588
0.01%
12/31/2017
City National Rochdale LLC
35,042
1.54%
0
0%
06/30/2018
Perkins Capital Management, Inc.
32,166
1.42%
-1,000
0.07%
06/30/2018
The Vanguard Group, Inc.
30,609
1.35%
-826
0%
06/30/2018
BlackRock Fund Advisors
26,477
1.15%
904
0%
06/30/2018
Barclays Capital, Inc.
18,187
0.8%
9,600
0%
06/30/2018
Creative Planning, Inc.
17,561
0.77%
223
0%
06/30/2018
Garrison, Bradford & Associates, Inc.
15,608
0.69%
15,088
0.04%
06/30/2018
Sabby Capital LLC
5,920
0.26%
2,841
0.01%
06/30/2018

About Biocept

View Profile
Address
5810 Nancy Ridge Drive
San Diego California 92121
United States
Employees -
Website http://www.biocept.com
Updated 07/08/2019
Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests.